Bijvoet G P, van der Sijs-Bos C J M, Wielders J P M, Groot O A
Department of Cardiology, Meander Medical Center, Amersfoort, the Netherlands.
Neth J Med. 2016 Jan;74(1):36-9.
In this case report we describe a 67-year-old male, admitted to the ICU with pneumonia who unexpectedly developed a fatal coma due to hyperammonaemia. At postmortem the diagnosis late-onset ornithine transcarbamylase deficiency was made. The non-specific clinical presentation, the rapid deterioration and incidentally the fatal outcome all underline the importance of recognition and knowledge of this genetic disorder. Several measures to treat and prevent potentially fatal episodes of hyperammonaemia are available, if only the disorder is recognised in time. In retrospect, several clues to the diagnosis were available in this fatal case, such as voluntary protein avoidance, as well as several male family members who died at a young age of an unknown cause. After his death, two daughters were discovered to be carriers of an OTC gene mutation, as well as his infant grandson. We emphasise the importance of obtaining ammonia levels in all patients with unexplained coma, seizures or cerebral oedema, irrespective of their age, especially in patients in the ICU or in an otherwise catabolic state.
在本病例报告中,我们描述了一名67岁男性,因肺炎入住重症监护病房(ICU),却意外因高氨血症发展为致命性昏迷。尸检时确诊为迟发性鸟氨酸转氨甲酰酶缺乏症。非特异性临床表现、病情迅速恶化以及最终的致命结局均凸显了识别和了解这种遗传性疾病的重要性。如果能及时识别该疾病,有多种治疗和预防高氨血症潜在致命发作的措施可供采用。回顾来看,这个致命病例中存在一些诊断线索,比如患者自觉避免蛋白质摄入,以及几位不明原因早逝的男性家庭成员。他去世后,发现两个女儿以及他尚在襁褓中的孙子是OTC基因突变携带者。我们强调,对于所有不明原因昏迷、癫痫发作或脑水肿的患者,无论其年龄大小,尤其是ICU患者或处于分解代谢状态的患者,检测血氨水平至关重要。